دورية أكاديمية
Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies.
| العنوان: | Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies. |
|---|---|
| المؤلفون: | Ochs J; Institute of Neuropathology, University Medical Center, Göttingen, Germany.; Department of Neurology, University Medical Center, Göttingen, Germany., Häusser-Kinzel S; Institute of Neuropathology, University Medical Center, Göttingen, Germany., Weber MS; Institute of Neuropathology, University Medical Center, Göttingen, Germany. martin.weber@med.uni-goettingen.de.; Department of Neurology, University Medical Center, Göttingen, Germany. martin.weber@med.uni-goettingen.de.; Fraunhofer Institute for Translational Medicine and Pharmacology, Göttingen, Germany. martin.weber@med.uni-goettingen.de. |
| المصدر: | Nature reviews. Immunology [Nat Rev Immunol] 2023 Sep; Vol. 23 (9), pp. 539-540. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124169 Publication Model: Print Cited Medium: Internet ISSN: 1474-1741 (Electronic) Linking ISSN: 14741733 NLM ISO Abbreviation: Nat Rev Immunol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London, UK : Nature Pub. Group, [c2001- |
| مواضيع طبية MeSH: | Antibodies, Monoclonal* , Trogocytosis*, Humans ; B-Lymphocytes ; Monocytes |
| References: | Frisch, E. S., Pretzsch, R. & Weber, M. S. A milestone in multiple sclerosis therapy: monoclonal antibodies against CD20 — yet progress continues. Neurotherapeutics 18, 1602–1622 (2021). (PMID: 10.1007/s13311-021-01048-z338807388609066) von Essen, M. R. et al. Proinflammatory CD20 + T cells in the pathogenesis of multiple sclerosis. Brain 142, 120–132 (2019). (PMID: 10.1093/brain/awy301) Ochs, J. et al. Proinflammatory CD20 + T cells contribute to CNS-directed autoimmunity. Sci. Transl. Med. 14, eabi4632 (2022). (PMID: 10.1126/scitranslmed.abi463235353539) Quendt, C., Ochs, J., Hausser-Kinzel, S., Hausler, D. & Weber, M. S. Proinflammatory CD20 + T cells are differentially affected by multiple sclerosis therapeutics. Ann. Neurol. 90, 834–839 (2021). (PMID: 10.1002/ana.2621634516013) Li, K. et al. Trogocytosis between non-immune cells for cell clearance, and among immune-related cells for modulating immune responses and autoimmunity. Int. J. Mol. Sci. 22, 2236 (2021). (PMID: 10.3390/ijms22052236336681177956485) Flanagan, E. P. et al. Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study. Mult. Scler. Relat. Disord. 57, 103352 (2022). (PMID: 10.1016/j.msard.2021.10335235158461) Mando, P., Rivero, S. G., Rizzo, M. M., Pinkasz, M. & Levy, E. M. Targeting ADCC: a different approach to HER2 breast cancer in the immunotherapy era. Breast 60, 15–25 (2021). (PMID: 10.1016/j.breast.2021.08.007344543238399304) Fu, Z., Li, S., Han, S., Shi, C. & Zhang, Y. Antibody drug conjugate: the ″biological missile″ for targeted cancer therapy. Signal Transduct. Target Ther. 7, 93 (2022). (PMID: 10.1038/s41392-022-00947-7353183098941077) Baba, E. et al. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand. J. Immunol. 167, 875–883 (2001). (PMID: 10.4049/jimmunol.167.2.87511441094) Croft, M., So, T., Duan, W. & Soroosh, P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol. Rev. 229, 173–191 (2009). (PMID: 10.1111/j.1600-065X.2009.00766.x194262222729757) |
| المشرفين على المادة: | 0 (Antibodies, Monoclonal) |
| تواريخ الأحداث: | Date Created: 20230725 Date Completed: 20230828 Latest Revision: 20230924 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1038/s41577-023-00920-7 |
| PMID: | 37491447 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!